Kerecis Ltd.
http://www.kerecis.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Kerecis Ltd.
Minute Insight: Coloplast Adds Icelandic Wound Care Innovator Kerecis For $1.3BN
Coloplast expects Kerecis' rapid growth to justify the high price of the acquisition. The Icelandic company's skin-substitute products are made from minimally processed cod skins.
Deal Watch: Dragonfly Adds Gilead To Its List Of Big-Name Partners
AbbVie inks collaboration and option deal focused on targeted protein degradation with Plexium. Cend and Calabrius merge in an all-stock transaction.
Medtech Execs On The Move, August 2013
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Biologics: The Growth Engine In Advanced Wound Care
With estimated revenues in excess of $5 billion per year worldwide, the advanced wound care market has garnered the attention of both major companies and investors for its tremendous potential. Growth in this market is being driven by the development of new bioactive products that can successfully heal chronic wounds such as diabetic foot ulcers, which are among the most challenging and costly to treat. This article is reprinted from the June issue of Medtech Insight.
Company Information
- Industry
- Biotechnology
-
Medical Devices
- Biomaterials
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice